Results 321 to 330 of about 436,571 (380)
Cancer-immune coevolution dictated by antigenic mutation accumulation. [PDF]
Wang L, Morison C, Huang W.
europepmc +1 more source
Mechanism and role of regulated cell death in tumor immunity and immunotherapy
Abstract Cancer immune checkpoint inhibitors (ICIs) have brought breakthroughs, but only about one‐third of cancer patients benefit from ICIs. In recent years, targeting non‐apoptotic regulated cell death (RCD) subtypes, such as ferroptosis, necroptosis, autophagy, cuproptosis, and pyroptosis, has emerged as a novel strategy in cancer therapy due to ...
Jingwen Hu +4 more
wiley +1 more source
Lipin3 deficiency promotes hepatocyte ferroptosis and pyroptosis via activating JAK1-STAT3 pathway during acetaminophen induced acute liver injury. [PDF]
Liu YX +5 more
europepmc +1 more source
Abstract Background Third‐generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) show initial efficacy in EGFR‐mutated lung cancer, but residual disease persists. This study aimed to investigate cluster of differentiation 24 (CD24) as a translational immunotherapeutic target for enhancing third‐generation EGFR‐TKI efficacy.
Jiaqi Liang +16 more
wiley +1 more source
The multifaceted impact of stress on immune function. [PDF]
Balcerowska M, Kwaśnik P.
europepmc +1 more source
This study explored the antibacterial, antivirulence, and in vivo effects of Algrizea minor essential oil (EOAM), against MRSA isolates. Chemical analysis by GC‐MS has been performed. The oil exhibited synergistic effects when combined with amoxicillin and oxacillin, inhibiting biofilm formation and reducing S. aureus‐induced hemolysis.
Amanda Vieira de Barros +14 more
wiley +1 more source
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells. [PDF]
Lotsch C +21 more
europepmc +1 more source
Design and Characterization of Prodrugged Anti‐CTLA‐4 Antibodies
Therapeutic antibodies are widely used to treat diseases like cancer and inflammatory conditions by binding with high specificity to their molecular targets. Masking is a strategy to mitigate undesirable activity in non‐target tissues, improving safety and pharmacokinetic (PK) profiles by reducing target‐mediated drug disposition (TMDD). In this study,
Sayumi Yamazoe +15 more
wiley +1 more source
Micro-nano microbial fuel cell-driven bioelectrochemical tumor therapy. [PDF]
Li R +11 more
europepmc +1 more source

